Similar Search Results

Advertising Regulations in Pharmaceutical Markets : Product versus Enlightenment

Ishida, Junichiro - 2019

This paper analyzes the optimal content regulation of direct-to-consumer advertisement (DTCA) in a pharmaceutical … typical subjective symptoms under enlightenment DTCA. The content regulation changes the nature of market competition and the … of the content regulation is ambiguous and depends, among other things, on the cost effectiveness of advertisement and …

Persistent link: https://www.econbiz.de/10012897821

Systemic Failure of Regulation : The Political Economy of Pharmaceutical and Bulk Drug Manufacturing

Vijay, Gudavarthy - 2017

This chapter challenges the myth of pharmaceuticals constituting a Sun Rise industry of great potential for the future … pharmaceuticals industry with competitive advantages in international markets. It explains a pattern of systemic regulatory failure … resulting in the bad manufacturing practice of pharmaceuticals and bulk drugs manufacturers dumping untreated toxic and …

Persistent link: https://www.econbiz.de/10012962899

The effect of inertia on brand-name versus generic drug choices

Ito, Yuki; Hara, Konan; Kobayashi, Yasuki - In: Journal of economic behavior & organization : JEBO 172 (2020), pp. 364-379

Persistent link: https://www.econbiz.de/10012288243

Understanding drugs markets : an analysis of medicines, regulations and pharmaceutical systems in the Global South

Baxerres, Carine (ed.); Cassier, Maurice (ed.) - 2022

"Drawing on anthropology, sociology and epidemiology, this multidisciplinary book investigates how pharmaceuticals are …

Persistent link: https://www.econbiz.de/10012428097

European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending

Golec, Joseph H. - 2006

EU countries closely regulate pharmaceutical prices whereas the U.S. does not. This paper shows how price constraints affect the profitability, stock returns, and R&D spending of EU and U.S. firms. Compared to EU firms, U.S. firms are more profitable, earn higher stock returns, and spend more on...

Persistent link: https://www.econbiz.de/10012465985